Effect of high dose norepinephrine versus epinephrine on cerebral and myocardial blood flow during CPR

Several animal studies have demonstrated an improvement in cerebral blood flow (CBF) and myocardial blood flow (MBF) after the administration of epinephrine (E) 0.20 mg/kg during closed chest CPR. The administration of norepinephrine (NE) in doses of 0.12 and 0.16 mg/kg demonstrated a trend toward i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Resuscitation 1990-06, Vol.19 (3), p.227-240
Hauptverfasser: Hoekstra, James W., Van Ligten, Peter, Neumar, Robert, Werman, Howard A., Brown, Judith AndersonCharles G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Several animal studies have demonstrated an improvement in cerebral blood flow (CBF) and myocardial blood flow (MBF) after the administration of epinephrine (E) 0.20 mg/kg during closed chest CPR. The administration of norepinephrine (NE) in doses of 0.12 and 0.16 mg/kg demonstrated a trend toward improved CBF and MBF during CPR over that seen with E 0.20 mg/kg in the same animal model. The purpose of this study was to compare the effects of a higher dose of NE 0.20 mg/kg to E 0.20 mg/kg to determine if increasing doses of NE would demonstrate further improvement in CBF and MBF during CPR. Fourteen immature swine were anesthetized and instrumented for regional blood flow and hemodynamic measurements. After 10 min of ventricular fibrillation (VF), CPR was begun using a mechanical thumper. After 3 min of CPR, the animals received either E 0.20 mg/kg ( n = 7) or NE 0.20 mg/kg ( n = 7) through a right atrial catheter. CPR was continued for an additional 3.5 min and defibrillation was then attempted. CBF (ml/min/100 g), MBF (ml/min/100 g), myocardial oxygen delivery (MDo 2; ml O 2/ min/100 g), myocardial oxygen consumption (MVo 2; ml O 2/min/100 g), and myocardial oxygen extraction ratios (ER, MVo 2 MDo 2 ) were measured during normal sinus rhythm (NSR), during CPR, and during CPR following drug administration. Following drug administration, CBF, MBF, MDo 2 and MVo 2 rose while ER fell in both E and NE groups. There were no significant differences between groups in CBF, ER, or intravascular pressures following drug administration ( P ⩾ 0.07). The NE group demonstrated significantly higher MBF (118.9 ± 73.1 vs. 62.2 ± 45.3, P = 0.04), MVo 2 (14.2 ± 7.7 vs. 7.0 ± 3.8, P = 0.05), and MDo 2 (19.9 ± 13.4 versus 9.4 ±0 6.3, P = 0.05) compared to the E group following drug administration While NE inproved MBF and MDo 2 over E during CPR, there was a trend toward lower resuscitation rates with NE (57. 1% vs. 85.7% P = 0.56). Any benefit of higher MBF and MDo 2 with NE 0.20 mg/kg appears to be offset by proportionately high MVo 2 and a trend toward lower resuscitation rates in the NE 0.20 mg/kg animals.
ISSN:0300-9572
1873-1570
DOI:10.1016/0300-9572(90)90104-M